SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-17-009658
Filing Date
2017-09-14
Accepted
2017-09-14 08:58:43
Documents
3
Period of Report
2017-09-14

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER f6k091417_biondvax.htm 6-K 19753
2 PRESS RELEASE DATED SEPTEMBER 13, 2017 f6k091417ex99-1_biondvax.htm EX-99.1 9967
3 GRAPHIC eximg_001.jpg GRAPHIC 13111
  Complete submission text file 0001213900-17-009658.txt   48908
Mailing Address 14 EINSTEIN ST. NES-ZIONA L3 74036
Business Address 14 EINSTEIN ST. NES-ZIONA L3 74036 972-8-9302529
BiondVax Pharmaceuticals Ltd. (Filer) CIK: 0001611747 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1213
Type: 6-K | Act: 34 | File No.: 001-37353 | Film No.: 171084678
SIC: 2836 Biological Products, (No Diagnostic Substances)